Sabby Management as of March 31, 2026
Portfolio Holdings for Sabby Management
Sabby Management holds 28 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Etf Put Option | 64.5 | $29M | 447.00 | 65034.00 | |
| Ishares Tr Etf Put Option | 16.5 | $7.4M | 300.00 | 24800.00 | |
| Spdr S&p 500 Etf Etf (SPY) | 3.9 | $1.8M | 2.7k | 650.34 | |
| Gevo Put Option | 3.2 | $1.4M | 5.3k | 273.00 | |
| Abivax Sa Ads Call Option | 1.9 | $857k | 77.00 | 11135.00 | |
| Alphaton Capital Corp SHS (ALP) | 1.5 | $655k | 2.1M | 0.32 | |
| Briacell Therapeutics Corp *W (BCTXL) | 0.9 | $392k | 381k | 1.03 | |
| Senestech (SNES) | 0.8 | $358k | 219k | 1.64 | |
| Big Tree Cloud Hldgs Cl A (DSY) | 0.7 | $337k | 138k | 2.45 | |
| Kempharm Put Option | 0.7 | $317k | 340.00 | 932.00 | |
| Briacell Therapeutics Corp (BCTX) | 0.7 | $310k | 74k | 4.19 | |
| Sidus Space Put Option | 0.5 | $243k | 1.0k | 232.00 | |
| Token Cat Ads (TC) | 0.5 | $242k | 23k | 10.40 | |
| Pop Culture Group SHS (CPOP) | 0.4 | $201k | 664k | 0.30 | |
| Moleculin Biotech (MBRX) | 0.4 | $172k | 75k | 2.29 | |
| Biodexa Pharmaceuticals Ads | 0.4 | $159k | 258k | 0.62 | |
| Arcadia Biosciences (RKDA) | 0.4 | $158k | 115k | 1.38 | |
| Trx Gold Corporation (TRX) | 0.3 | $150k | 100k | 1.50 | |
| Inmed Pharmaceuticals (INM) | 0.3 | $142k | 220k | 0.64 | |
| Can Fite Biofarma Adr (CANF) | 0.3 | $132k | 43k | 3.10 | |
| China Sxt Pharmaceuticals Cl A (SXTC) | 0.3 | $131k | 78k | 1.68 | |
| Revelation Biosciences (REVB) | 0.3 | $119k | 99k | 1.20 | |
| Calidi Biotherapeutics (CLDI) | 0.2 | $104k | 435k | 0.24 | |
| Bluejay Diagnostics (BJDX) | 0.1 | $53k | 29k | 1.84 | |
| Lyra Therapeutics (LYRA) | 0.1 | $51k | 104k | 0.49 | |
| Tempest Therapeutics (TPST) | 0.1 | $29k | 18k | 1.64 | |
| Briacell Therapeutics Corp *W (BCTXZ) | 0.1 | $29k | 207k | 0.14 | |
| Applied Dna Sciences (BNBX) | 0.0 | $8.7k | 14k | 0.64 |